Following the recent closure of borders and travel restrictions to check the spread of the Coronavirus, the National Agency for Food and Drug Administration and Control (NAFDAC) has now announced that it would ensure emergency approvals for products necessary and critical to support response to the pandemic.
This is part of the control measures put up by the agency to help the country contain the COVID-19.
The information was contained in a statement released by the Director-General of the agency, Prof. Mojisola Adeyeye, on Tuesday in Abuja.
According to Adeyeye, the measures would help provide adequate protection for staff and clients of the agency in its position as a regulatory institution, while also helping the country as it combats the novel virus.
[READ MORE: VP Osinbajo in self-isolation over Coronavirus)
Adeyeye noted that the agency would limit Good Manufacturing Practice (GMP) inspections for local facilities at this period, to encourage local production of the critical items.
She added that the conduct of GMP of foreign facilities cannot be undertaken due to the pandemic and the current travel restriction on international travel for public officers, hence application for registration of products deemed to have urgent public health impact would be processed and given conditional approvals.
The agency added that all regulatory processes would continue and NAFDAC remains operational with restricted access in place so that stakeholders could engage via emails and other functional electronic platforms.
“The situation is fast evolving and we will continue to monitor and adjust our responses accordingly. For further information, visit our website: nafdac.gov.ng.
“The agency wishes to assure the public that it remains committed to safeguarding public health and executing its mandate by ensuring that regulated products meet set standards,” Adeyeye said in her statement.
[READ ALSO: Lagos state to shut down markets)
What this means: This development could see a surge in the number of local manufacturers for products vital to the control of Coronavirus such as hand sanitizers and masks, to make up for the current deficit in supply.
In recent weeks, prices of these vital items have been hiked by sellers, even as buyers scramble to get them at whatever cost. The travel restrictions in several countries, coupled with the panic buying have created an undue scarcity for the items, as families seek to protect themselves.
The number of confirmed cases across the globe continues to surge daily.
As of Tuesday evening, the Nigerian Centre for Disease Control announced the confirmation of two new cases, bringing the total figure in Nigeria to 44.
COVID-19 Update in Nigeria
On the 21st of April 2021, 65 new confirmed cases were recorded in Nigeria
The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increases as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 164,488 confirmed cases.
On the 21st of April 2021, 65 new confirmed cases were recorded in Nigeria.
To date, 164,488 cases have been confirmed, 154,441 cases have been discharged and 2,061 deaths have been recorded in 36 states and the Federal Capital Territory.
A total of 1.84 million tests have been carried out as of 21st April 20th, 2021 compared to 1.81 million tests a day earlier.
COVID-19 Case Updates- 21st April 2021,
- Total Number of Cases – 164,488
- Total Number Discharged – 154,441
- Total Deaths – 2,061
- Total Tests Carried out – 1,838,174
According to the NCDC, the 65 new cases are reported from 11 states- Lagos (41), Kaduna (6), Kano (3), Rivers (3), Plateau (3), Akwa Ibom (2), Imo (2), Oyo (2), Edo (1), Bauchi (1), and Osun (1).
Meanwhile, the latest numbers bring Lagos state total confirmed cases to 58,209, followed by Abuja (19,754), Plateau (9,049), Kaduna (9,036), Rivers (7,070), Oyo (6,842), Edo (4,898), Ogun (4,647), Kano (3,942), Ondo (3,226), Kwara (3,120), Delta (2,617), Osun (2,572), Nasarawa (2,380), Enugu (2,281), Katsina (2,097), Gombe (2,034), Ebonyi (2,020), Anambra (1,909), Akwa Ibom (1,843), and Abia (1,683).
Imo State has recorded 1,655 cases, Bauchi (1,540), Borno (1,337), Benue (1,188), Adamawa (1,063), Niger (930), Taraba (910), Bayelsa (885), Ekiti (869), Sokoto (775), Jigawa (527), Kebbi (450), Cross River (394), Yobe (365), Zamfara (240), while Kogi state has recorded 5 cases only.
Lock Down and Curfew
In a move to combat the spread of the pandemic disease, President Muhammadu Buhari directed the cessation of all movements in Lagos and the FCT for an initial period of 14 days, which took effect from 11 pm on Monday, 30th March 2020.
The movement restriction, which was extended by another two weeks period, has been partially put on hold with some businesses commencing operations from May 4. On April 27th, 2020, Nigeria’s President, Muhammadu Buhari declared an overnight curfew from 8 pm to 6 am across the country, as part of new measures to contain the spread of the COVID-19. This comes along with the phased and gradual easing of lockdown measures in FCT, Lagos, and Ogun States, which took effect from Saturday, 2nd May 2020, at 9 am.
On Monday, 29th June 2020 the federal government extended the second phase of the eased lockdown by 4 weeks and approved interstate movement outside curfew hours with effect from July 1, 2020. Also, on Monday 27th July 2020, the federal government extended the second phase of eased lockdown by an additional one week.
On Thursday, 6th August 2020 the federal government through the secretary to the Government of the Federation (SGF) and Chairman of the Presidential Task Force (PTF) on COVID-19 announced the extension of the second phase of eased lockdown by another four (4) weeks.
Governor Babajide Sanwo-Olu of Lagos State announced the closed down of the Eti-Osa Isolation Centre, with effect from Friday, 31st July 2020. He also mentioned that the Agidingbi Isolation Centre would also be closed and the patients relocated to a large capacity centre.
Due to the increased number of covid-19 cases in Nigeria, the Nigerian government ordered the reopening of Isolation and treatment centres in the country on Thursday, 10th December 2020.
On 26th January 2021, the Federal Government announced the extension of the guidelines of phase 3 of the eased lockdown by one month following the rising cases of the coronavirus disease in the country and the expiration of phase 3 of the eased lockdown.
On 28th February 2021, the federal government confirmed that the first tranche of Covid-19 vaccines will arrive in Nigeria on Tuesday, March 2nd, 2021.
On Tuesday, 2nd March 2021, the National Primary health Care Development Agency announced the arrival of the expected COVX Astrazeneca/Oxford covid-19 vaccines.
On Saturday, 6th March 2021, President Muhammadu Buhari and his vice, Yemi Osinbajo received vaccination against the covid-19 as the State House in Abuja.
FG explains how the Covid-19 vaccines work and their composition
The NPHCDA Director said that Covid-19 vaccine candidates are of various categories based on their mechanism of action.
The Federal Government through the National Primary Health Care Development Agency (NPHCDA) has explained the composition of the Covid-19 vaccines and how they work.
This is as some of them have been approved for emergency use by the World Health Organization (WHO) and some countries, while others are still at different phases of clinical trials for possible approval.
According to a report from the News Agency of Nigeria (NAN), this insight was given by the Executive Director/Chief Executive of NPHCDA, Dr Faisal Shuaib, who said there were several COVID-19 vaccine candidates.
He said that Covid-19 vaccine candidates are of various categories based on their mechanism of action such as the inactivated or weakened virus vaccines.
He explained that the idea behind the formulation of an inactivated or weakened virus vaccine is to elicit an immune response without causing the disease itself. Shuaib also said there were protein-based vaccines, which used harmless fragments of proteins or protein shells that mimic the Covid-19 virus to safely generate an immune response.
He added that the viral vector vaccines used a virus that had been genetically engineered to produce coronavirus proteins to safely generate an immune response and not give rise to the disease.
Going further, Shuaib pointed out that the Ribonucleic Acid (RNA) and Deoxyribonucleic Acid (DNA) vaccines employed a cutting-edge approach that used genetically engineered RNA or DNA to generate a protein that safely prompted an immune response.
What you should know
- It can be recalled that on March 2, 2021, Nigeria received the first set of about 4 million doses of the AstraZeneca Covid-19 vaccine, manufactured by the Serum Institute in India and shipped via the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO.
- A few days ago, the Executive Director of NPHCDA disclosed that a total of 8,491 Nigerians have reacted adversely to the AstraZeneca inoculation since the exercise began on March 15.
- He said that Nigeria recorded 52 cases of moderate to severe incidents of Adverse Effects Following Immunisation (AEFI), presented as fever, vomiting, diarrhoea headaches, dizziness and allergic reactions.
- About 1.09 million Nigerians have so far been administered the first dose of the AstraZeneca Covid-19 vaccine.
Nairametrics | Company Earnings
Access our Live Feed portal for the latest company earnings as they drop.
- VFD Group set to raise additional capital of N9.01 billion through rights issue and private placement.
- GT Bank records a 9% dip in profit to N45.55 billion in Q1 2021.
- Secure Electronic Technology Plc records a 121% surge in Profit after tax in Q1 2021.
- Lafarge Africa Plc notifies stakeholders of 62nd Annual General Meeting.
- GlaxoSmithKline (GSK) announces Annual General Meeting.